CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis

[1]  R. de Caterina,et al.  NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis. , 2023, Cardiovascular research.

[2]  L. Goracci,et al.  A platelet lipidomics signature in patients with COVID-19 , 2023, Platelets.

[3]  K. Ferreira-Paim,et al.  Inflammatory Response and Activation of Coagulation after COVID-19 Infection , 2023, Viruses.

[4]  M. Rizzo,et al.  Alteration in Redox Status and Lipoprotein Profile in COVID-19 Patients with Mild, Moderate, and Severe Pneumonia , 2022, Oxidative medicine and cellular longevity.

[5]  C. Maertens de Noordhout,et al.  Pathophysiology and mechanism of long COVID: a comprehensive review , 2022, Annals of medicine.

[6]  L. BenMohamed,et al.  SARS-CoV-2 Envelope (E) Protein Binds and Activates TLR2 Pathway: A Novel Molecular Target for COVID-19 Interventions , 2022, Viruses.

[7]  R. Silverstein,et al.  CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate , 2022, The Journal of experimental medicine.

[8]  E. Lundevaller,et al.  Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study , 2022, BMJ.

[9]  F. Otsuka,et al.  Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registry. , 2022, Atherosclerosis.

[10]  L. Buée,et al.  Impaired Glucose Homeostasis in a Tau Knock-In Mouse Model , 2022, Frontiers in Molecular Neuroscience.

[11]  J. Niu,et al.  Platelets mediate inflammatory monocyte activation by SARS-CoV-2 spike protein , 2021, The Journal of clinical investigation.

[12]  Kelly V. Ruggles,et al.  Platelets contribute to disease severity in COVID‐19 , 2021, Journal of Thrombosis and Haemostasis.

[13]  Gong Yang,et al.  Extracellular matrix protein-1 secretory isoform promotes ovarian cancer through increasing alternative mRNA splicing and stemness , 2021, Nature Communications.

[14]  C. Jonsson,et al.  TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines , 2021, Nature Immunology.

[15]  T. Cokelaer,et al.  COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters , 2021, Science Translational Medicine.

[16]  Dave L Dixon,et al.  Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 , 2021, Nature Reviews Immunology.

[17]  Xiangxi Wang,et al.  SARS-CoV-2 spike protein interacts with and activates TLR41 , 2021, Cell Research.

[18]  P. Lehner,et al.  No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor , 2021, Scientific Reports.

[19]  M. Revel,et al.  Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis , 2020, Radiology.

[20]  Robert A. Campbell,et al.  Is there a role for the ACE2 receptor in SARS‐CoV‐2 interactions with platelets? , 2020, Journal of Thrombosis and Haemostasis.

[21]  Shenmin Zhang,et al.  SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19 , 2020, Journal of Hematology & Oncology.

[22]  Nicolas Carlier,et al.  Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients , 2020, Science.

[23]  Gengfu Xiao,et al.  SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target , 2020, Cell Research.

[24]  Robert A. Campbell,et al.  Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome , 2020, Blood.

[25]  Robert A. Campbell,et al.  Platelet gene expression and function in patients with COVID-19 , 2020, Blood.

[26]  I. Mingarro,et al.  SARS-CoV-2 envelope protein topology in eukaryotic membranes , 2020, bioRxiv.

[27]  Mickaël Ohana,et al.  High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study , 2020, Intensive Care Medicine.

[28]  Nils Kucher,et al.  Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy , 2020, Thrombosis Research.

[29]  M. Laffan,et al.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.

[30]  Ke Ma,et al.  Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study , 2020, BMJ.

[31]  Dengju Li,et al.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.

[32]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[33]  B. Fielding,et al.  Coronavirus envelope protein: current knowledge , 2019, Virology Journal.

[34]  Xisheng Liu,et al.  USP10 regulates Musashi‐2 stability via deubiquitination and promotes tumour proliferation in colon cancer , 2019, FEBS letters.

[35]  J. Heemskerk,et al.  Platelet biology and functions: new concepts and clinical perspectives , 2018, Nature Reviews Cardiology.

[36]  S. Jacob,et al.  Dose translation between laboratory animals and human in preclinical and clinical phases of drug development , 2018, Drug development research.

[37]  Huiming Sun,et al.  Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway , 2018, Journal of Cancer Research and Clinical Oncology.

[38]  J. Torres,et al.  MERS coronavirus envelope protein has a single transmembrane domain that forms pentameric ion channels , 2015, Virus Research.

[39]  A. Walch,et al.  Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo , 2012, The Journal of experimental medicine.

[40]  Guoqiang Chen,et al.  PTEN regulates collagen-induced platelet activation. , 2010, Blood.

[41]  Jincun Zhao,et al.  Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease , 2010, Virology.

[42]  Xiaoping Du,et al.  Src family tyrosine kinase Lyn mediates VWF/GPIb-IX-induced platelet activation via the cGMP signaling pathway. , 2008, Blood.

[43]  Junling Liu,et al.  Bruton tyrosine kinase is essential for botrocetin/VWF-induced signaling and GPIb-dependent thrombus formation in vivo. , 2006, Blood.